(Q34474591)

2 August 2017

1 reference

title

Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited (English)

1 reference

2 August 2017

0 references

1 reference

J T Tamsma

1

1 reference

2 August 2017

H J Keizer

series ordinal

2

1 reference

2 August 2017

A E Meinders

series ordinal

3

1 reference

2 August 2017

publication date

1 October 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

12

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

1353-1357

1 reference

Ultrastructure of normal rabbit mesentery

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Ascites, pathophysiology and control measures

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

A concept of negative interstitial pressure based on pressures in implanted perforated capsules

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Active transendothelial transport of albumin. Interstitium to lumen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Ascitic fluid analysis in malignancy-related ascites

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Pathogenesis of Ascites in Mice With Peritoneal Carcinomatosis 2

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

A study of ascites using lymphoscintigraphy with 99m Tc-sulfur colloid

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

A quantitative measurement of peritoneal drainage in malignant ascites

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Genesis of ascites in ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Markedly elevated levels of vascular endothelial growth factor in malignant ascites

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

VEGF/Flk-1 interaction, a requirement for malignant ascites recurrence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012504904713

7 January 2021

Identifiers

DOI

10.1023/A:1012504904713

1 reference

2 August 2017

1 reference